Edwards Lifesciences Net Profit Margin 2010-2023 | EW
Current and historical net profit margin for Edwards Lifesciences (EW) from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue. Edwards Lifesciences net profit margin for the three months ending December 31, 2023 was .
| Edwards Lifesciences Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $6.01B | $1.40B | 23.36% |
| 2023-09-30 | $5.82B | $1.43B | 24.59% |
| 2023-06-30 | $5.66B | $1.39B | 24.57% |
| 2023-03-31 | $5.50B | $1.49B | 27.07% |
| 2022-12-31 | $5.38B | $1.52B | 28.28% |
| 2022-09-30 | $5.36B | $1.46B | 27.20% |
| 2022-06-30 | $5.36B | $1.46B | 27.17% |
| 2022-03-31 | $5.36B | $1.54B | 28.73% |
| 2021-12-31 | $5.23B | $1.50B | 28.72% |
| 2021-09-30 | $5.10B | $1.48B | 29.01% |
| 2021-06-30 | $4.93B | $1.46B | 29.70% |
| 2021-03-31 | $4.48B | $0.85B | 19.02% |
| 2020-12-31 | $4.39B | $0.82B | 18.78% |
| 2020-09-30 | $4.37B | $0.79B | 18.17% |
| 2020-06-30 | $4.32B | $0.74B | 17.21% |
| 2020-03-31 | $4.48B | $1.11B | 24.71% |
| 2019-12-31 | $4.35B | $1.05B | 24.08% |
| 2019-09-30 | $4.15B | $0.77B | 18.64% |
| 2019-06-30 | $3.97B | $0.73B | 18.28% |
| 2019-03-31 | $3.82B | $0.77B | 20.04% |
| 2018-12-31 | $3.72B | $0.72B | 19.41% |
| 2018-09-30 | $3.64B | $0.71B | 19.61% |
| 2018-06-30 | $3.55B | $0.66B | 18.51% |
| 2018-03-31 | $3.45B | $0.56B | 16.24% |
| 2017-12-31 | $3.44B | $0.58B | 16.96% |
| 2017-09-30 | $3.32B | $0.75B | 22.47% |
| 2017-06-30 | $3.23B | $0.72B | 22.15% |
| 2017-03-31 | $3.15B | $0.66B | 20.86% |
| 2016-12-31 | $2.96B | $0.57B | 19.24% |
| 2016-09-30 | $2.87B | $0.55B | 19.26% |
| 2016-06-30 | $2.74B | $0.53B | 19.29% |
| 2016-03-31 | $2.60B | $0.52B | 19.80% |
| 2015-12-31 | $2.49B | $0.50B | 19.85% |
| 2015-09-30 | $2.44B | $0.46B | 18.97% |
| 2015-06-30 | $2.43B | $0.44B | 18.09% |
| 2015-03-31 | $2.39B | $0.87B | 36.57% |
| 2014-12-31 | $2.32B | $0.81B | 34.93% |
| 2014-09-30 | $2.24B | $0.78B | 34.69% |
| 2014-06-30 | $2.13B | $0.76B | 35.65% |
| 2014-03-31 | $2.07B | $0.31B | 14.73% |
| 2013-12-31 | $2.05B | $0.39B | 19.01% |
| 2013-09-30 | $2.02B | $0.40B | 19.95% |
| 2013-06-30 | $1.97B | $0.40B | 20.03% |
| 2013-03-31 | $1.94B | $0.37B | 19.10% |
| 2012-12-31 | $1.90B | $0.29B | 15.32% |
| 2012-09-30 | $1.82B | $0.27B | 14.57% |
| 2012-06-30 | $1.78B | $0.25B | 13.90% |
| 2012-03-31 | $1.73B | $0.24B | 13.73% |
| 2011-12-31 | $1.68B | $0.24B | 14.12% |
| 2011-09-30 | $1.64B | $0.24B | 14.56% |
| 2011-06-30 | $1.58B | $0.24B | 14.90% |
| 2011-03-31 | $1.51B | $0.24B | 15.55% |
| 2010-12-31 | $1.45B | $0.22B | 15.13% |
| 2010-09-30 | $1.40B | $0.20B | 14.41% |
| 2010-06-30 | $1.38B | $0.23B | 16.53% |
| 2010-03-31 | $1.35B | $0.22B | 16.15% |
| 2009-12-31 | $1.32B | $0.23B | 17.46% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $51.275B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.933B | 26.53 |
| Intuitive Surgical (ISRG) | United States | $135.870B | 81.85 |
| DexCom (DXCM) | United States | $51.560B | 78.10 |
| IQVIA Holdings (IQV) | United States | $41.367B | 24.00 |
| Alcon (ALC) | Switzerland | $39.650B | 29.24 |
| IDEXX Laboratories (IDXX) | United States | $39.383B | 46.16 |
| STERIS (STE) | Ireland | $20.704B | 24.50 |
| Waters (WAT) | United States | $18.971B | 27.22 |
| Hologic (HOLX) | United States | $17.720B | 19.83 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.280B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.570B | 15.52 |
| ShockWave Medical (SWAV) | United States | $12.378B | 77.10 |
| Sysmex ADR (SSMXY) | Japan | $11.001B | 34.50 |
| Teleflex (TFX) | United States | $9.466B | 14.73 |
| Penumbra (PEN) | United States | $8.202B | 101.25 |
| Masimo (MASI) | United States | $7.302B | 40.95 |
| Globus Medical (GMED) | United States | $6.805B | 21.58 |
| Glaukos (GKOS) | United States | $5.289B | 0.00 |
| TransMedics (TMDX) | United States | $4.369B | 414.53 |
| Integer Holdings (ITGR) | United States | $3.743B | 22.62 |
| LivaNova (LIVN) | United Kingdom | $3.390B | 20.13 |
| PROCEPT BioRobotics (PRCT) | United States | $3.159B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.810B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.789B | 19.13 |
| Nihon Kohden (NHNKY) | Japan | $2.518B | 21.30 |
| Inari Medical (NARI) | United States | $2.433B | 0.00 |
| RxSight (RXST) | United States | $2.324B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.857B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.819B | 7.95 |
| Veracyte (VCYT) | United States | $1.599B | 0.00 |
| OPKO Health (OPK) | United States | $0.920B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.906B | 17.62 |
| Paragon 28 (FNA) | United States | $0.885B | 0.00 |
| Artivion (AORT) | United States | $0.868B | 84.28 |
| Silk Road Medical (SILK) | United States | $0.824B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.799B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.692B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.624B | 21.20 |
| SiBone (SIBN) | United States | $0.597B | 0.00 |
| IRadimed (IRMD) | United States | $0.552B | 30.92 |
| Pacific Biosciences Of California (PACB) | United States | $0.542B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.503B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.427B | 0.00 |
| Nevro (NVRO) | United States | $0.409B | 0.00 |
| NeuroPace (NPCE) | United States | $0.387B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 11.54 |
| Sight Sciences (SGHT) | United States | $0.288B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.248B | 0.00 |
| AxoGen (AXGN) | United States | $0.248B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.216B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.195B | 10.48 |
| 908 Devices (MASS) | United States | $0.194B | 0.00 |
| Accuray (ARAY) | United States | $0.178B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.161B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.160B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.106B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Envoy Medical (COCH) | United States | $0.067B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.062B | 125.33 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.059B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.052B | 0.00 |
| InspireMD (NSPR) | Israel | $0.050B | 0.00 |
| DarioHealth (DRIO) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.039B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.020B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |